Dr. Sharlene Day graduated from the Massachusetts Institute of Technology and received her MD degree from New York University School of Medicine. She completed her internal medicine residency and cardiovascular medicine fellowship at the University of Michigan.

Dr. Carolyn Ho is an Assistant Professor of Medicine at Harvard Medical School and Medical Director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital.

Trained in Florence and London, Dr. Olivotto has pursued a career in Emergency Medicine and subsequently in Cardiology at Careggi University Hospital in Florence, Italy, where he currently serves as staff physician.

Dr. Parikh is cardiologist specializing in the care of patients with inherited cardiovascular diseases. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by research grant from the NIH, she currently studies multiple causes of cardiomyopathy in the laboratory. She has a particular clinical and scientific interest in inherited arrhythmogenic cardiomyopathies, which are an increasingly recognized disease entity. Dr. Parikh is currently using patient cohort genetics, high throughput molecular biology and human induced pluripotent stem cell derived cardiomyocytes to study variant pathogenicity in this disease.

Dr. Lakdawala is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He received his medical degree from The University of Texas HSCSA. He completed a residency and chief residency in internal medicine at Columbia-Presbyterian Medical Center, a clinical and research fellowship in cardiovascular disease at BWH and a master’s degree in epidemiology at the Harvard School of Public Health. Dr. Lakdawala is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology. His clinical expertise includes cardiomyopathy, cardiac sarcoidosis, congestive heart failure, cardiovascular genetics and heart transplantation. Dr. Lakdawala’s research and peer-reviewed publications investigate early phenotypes in genetic cardiomyopathy to identify physiology-based therapeutics for heart failure.

Dr. Prasad’s primary field of interest is myocarditis and cardiomyopathy, and the use of MRI in early detection and diagnosis. He is on the editorial board for the Journal of Cardiovascular Magnetic Resonance, a journal that produces articles on all aspects of basic, translational and clinical research on the design, development, manufacturing, and evaluation of cardiovascular magnetic resonance (CMR) methods applied to the cardiovascular system. He is also a member of the International Myocarditis Consensus Panel and is part of the Fulbright Selection Committee.

Dr. Heymans is Professor of Cardiomyopathies and Head of the Centre for Heart Failure Research, Department of Cardiology, Maastricht University. He obtained his Medical Degree from the KULeuven (Belgium) in 1995 and went on to get a PhD in Medical Sciences in 2000, studying the role of proteinases in acute myocardial infarction. In 2003, He joined the Cardiology Department University Hospital of Maastricht (The Netherlands) as an academic medical specialist and in 2006 he took over the Multidisciplinary Cardiomyopathy Program (Genetics, Immunology, Microbiology and Pathology departments).
In 2008 he established his independent research laboratory at Cardiovascular Research Institute Maastricht. His research interests focus on the molecular mechanisms of heart failure, looking at the interplay between inflammatory cells, fibroblasts and cardiomyocytes. Particular focus is on the role of non-structural matrix proteins, matrix turnover and non-coding RNAs.